Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.
Bissonnette R, Eichenfield LF, Simpson E, Thaçi D, Kabashima K, Thyssen JP, Guttman-Yassky E, Nunes FP, Gamalo M, Ahmad F, Kuligowski M, Sun K, Pipper C, Christensen AW, D'Angelo P, Milutinovic M, Guettner A, Silverberg JI. Bissonnette R, et al. J Eur Acad Dermatol Venereol. 2023 May;37(5):976-983. doi: 10.1111/jdv.18881. Epub 2023 Feb 25. J Eur Acad Dermatol Venereol. 2023. PMID: 36652273 Review.
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.
Eichenfield LF, Simpson EL, Papp K, Szepietowski JC, Blauvelt A, Kircik L, Silverberg JI, Siegfried EC, Kuligowski ME, Venturanza ME, Kallender H, Ren H, Paller AS. Eichenfield LF, et al. Among authors: kuligowski me. Am J Clin Dermatol. 2024 May 2. doi: 10.1007/s40257-024-00855-2. Online ahead of print. Am J Clin Dermatol. 2024. PMID: 38698175
Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies.
Blauvelt A, Szepietowski JC, Papp K, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Kircik L. Blauvelt A, et al. Among authors: kuligowski me. J Am Acad Dermatol. 2023 Mar;88(3):651-653. doi: 10.1016/j.jaad.2022.09.010. Epub 2022 Sep 14. J Am Acad Dermatol. 2023. PMID: 36113614 Free article. No abstract available.
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis.
Blauvelt A, Kircik L, Papp KA, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Szepietowski JC. Blauvelt A, et al. Among authors: kuligowski me. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):137-146. doi: 10.1111/jdv.18571. Epub 2022 Sep 21. J Eur Acad Dermatol Venereol. 2023. PMID: 36066323 Free PMC article. Clinical Trial.
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies.
Papp K, Szepietowski JC, Kircik L, Toth D, Eichenfield LF, Leung DYM, Forman SB, Venturanza ME, Sun K, Kuligowski ME, Simpson EL. Papp K, et al. Among authors: kuligowski me. J Am Acad Dermatol. 2021 Oct;85(4):863-872. doi: 10.1016/j.jaad.2021.04.085. Epub 2021 May 4. J Am Acad Dermatol. 2021. PMID: 33957195 Free article. Clinical Trial.
14 results